Skip to content
DataLookout
Menu

SEPTA PMCFNCT07209852

Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up

StatusActive, Not Recruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 20 versions: 16 with changes below, 4 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Minor Enrollment target: estimated 140 to confirmed 141
  2. Minor Enrollment closed, study ongoing
    • Site details revised at 13 of 13 sites
  3. Minor Site details revised at 2 of 13 sites
  4. Notable Eligibility criteria expanded, about 24 words
  5. Minor Site details revised at 1 of 13 sitesv15
Show 10 earlier versionsHide 10 earlier versions
  1. Minor Site details revised at 1 of 13 sitesv14
  2. Minor Site details revised at 1 of 13 sitesv13
  3. Minor Site details revised at 3 of 13 sitesv12
  4. Minor Site details revised at 1 of 13 sitesv11
  5. Minor Site details revised at 1 of 13 sitesv10
  6. Minor Site details revised at 1 of 13 sitesv7
  7. Minor Site details revised at 1 of 13 sitesv6
  8. Minor Study sites: 12 to 13v5
  9. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 10 to 12
    • Start date: Jan 15, 2026 to Dec 19, 2025
    v4
  10. Minor Study sites: 0 to 10v2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

LBBA Implant Success Rate
Timeframe: At the time of implant procedure (Day 0).
Maintenance of Ventricular Synchrony (Paced QRS Duration)
Timeframe: From implant through 3-year follow-up.

Arms and interventions

Patients receiving INGEVITY+ lead for left bundle branch area pacing

This group includes adult patients with bradycardia who are indicated for a Boston Scientific pacemaker system. All participants will undergo implantation of an INGEVITY+ pace/sense lead in the left bundle branch area (LBBAP) with a compatible Boston Scientific pacemaker.

Devices: Pacemaker lead

Sites

13 sites in 7 countries

Italy 3, Belgium 2, France 2, Germany 2, Spain 2, Switzerland 1, United Kingdom 1